Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Medicare premium fix fails to deal with deeper problems at FDA

By Patrick A. Malone on October 5, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

eisaibiogenlogo-300x110Seniors had reason to let out a whimper of pleasure when the Biden Administration announced that Medicare’s monthly, part B premiums would go down by 3% next year — the first such decline in a decade.

To be sure, the sums that they will save will be small, with most of those covered on the government insurance program next year paying $164.90 a month for Part B and seeing a savings of $5.20. But over the course of 2023, administration officials say, this sum will help seniors recoup what they were charged in 2022 when they were hit one of the largest, single-year Medicare premium increases in recent times.

So, while the head-spinning fiscal mess of Medicare costs may be straightening out a tad, the underlying debacle that caused it all is still festering and ready to cause more prescription drug regulatory fiascoes.

Continue reading
Photo of Patrick A. Malone Patrick A. Malone
Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    DC Medical Malpractice & Patient Safety Blog
  • Organization:
    Patrick Malone & Associates
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo